Usefulness of gram-stained sputum obtained just after administration of antimicrobial agents as the earliest therapeutic indicator for evaluating the effectiveness of empiric therapy in community-acquired pneumonia caused by pneumococcus or Moraxella catarrhalis

Journal of Infection and Chemotherapy

Volumn 19, Issue 3, 2013, Pages 517-523

  Fujisaki, Ryuichi ^a   Yamaoka, Toshimori ^a   Yamamura, Michiko ^a   Kawakami, Sayoko ^b   Ono, Yasuo ^b   Miyazawa, Yukihisa ^b   Teramoto, Tamio ^a   Nishiya, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Community acquired pneumonia; Gram staining; Moraxella catarrhalis; Streptococcus pneumoniae; Therapeutic indicator

Indexed keywords

AMPICILLIN; AZITHROMYCIN; C REACTIVE PROTEIN; CEFOTAXIME; MACROLIDE; PENICILLIN G;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ATELECTASIS; CASE REPORT; COLD; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COUGHING; DRUG SCREENING; DYSLIPIDEMIA; ELECTROCARDIOGRAM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GRAM STAINING; HUMAN; HYPERTENSION; LABORATORY TEST; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIVER DYSFUNCTION; MALAISE; MALE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MYELOMA; NEUTROPHIL COUNT; OVARY TERATOMA; OXYGEN SATURATION; PHYSICAL EXAMINATION; PNEUMONIA; PROTEINURIA; RHINORRHEA; SINUS TACHYCARDIA; SORE THROAT; SPUTUM ANALYSIS; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; TACHYCARDIA;

EID: 84879247554     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0475-7     Document Type: Article

References (17)

1. Garou J, Calbo E. Community-acquired pneumonia. Lancet. 2008;371:455-8.
2. Restrepo MI, Anzueto A. Guidelines for the diagnoses and treatment of adult lower respiratory tract infections: a true "European cooperative effort". Eur Respir J. 2005;26:979-81.
3. Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ. 2006;332:1077-9.
4. Fine MJ, Smith MA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:134-41.
5. Ewig S, Schlochtermeier M, Göke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002;121:1486-92.
6. Theerhakarai R, EI-Halees W, Ismal M, Solis RA, Khan MA. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest. 2001;119:181-4.
7. Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000;31:869-74.
8. The American Thoracic Society. Guidelines for the management of adults with community-aquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-54.
9. The Committee for the JRS Guidelines in Management of Community-Acquired Pneumonia. In: Matsushima T, Kohno S, Saito A, Nakata K, Yamaguch K, Watanabe A, editors. Practice guideline for the management of community-acquired pneumonia in adults. Tokyo: The Japanese Respiratory Society; 2000 (in Japanese).
10. Matsumoto K, Uzuka Y, Taguchi M, et al. Sputum bacteria quantification culture. Media Circle 1985;19:181-99 (in Japanese).
11. Kanno S. Gram stain. Medicina 2005;42:545-48 (in Japanese).
12. Miyashita N, Shimizu H, Ouchi K, Kawasaki K, Kawai Y, Obase Y, Kobashi Y, Oka M. Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit. 2008;14:CR171-6.
13. Anevlavis S, Petroglou N, Tzavaras A, Maltezos E, Pneumatikos I, Froudarakis M, Anevlavis Bouros E. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect. 2009;59:83-9.
14. Sato T, Aoshima M, Ohmagari N, Tada H, Chohnabayashi N. Usefulness of sputum Gram staining in community-acquired pneumonia. Nihon Kokyuki Gakkai Zasshi. 2002;40:558-63 (Abstract).
15. Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med. 2006;45:419-28.
16. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community acquired pneumonia. Chest. 1995;108:1288-91.
17. Ikai H, Morimoto T, Shimbo T, Imanaka Y, Koike K. Impact of postgraduate education on physician practice for community-acquired pneumonia. J Eval Clin Pract. 2012;18:389-95.